Author: ICWA

Are vaccine aluminum adjuvants safe?

Are vaccine aluminum adjuvants safe?

Dr. Jose G. Dores, a professor at the University of Brasilia’s Department of Nutritional Sciences who recently published a study in the International Journal of Environmental Research and Public Health, offers the following observation:

“Despite their long use as active agents of medicines and fungicides, the safety levels of these substances have never been determined, either for animals or for adult humans, much less for fetuses, newborns, infants, and children.”


And a team of researchers, published in the Journal of Inorganic Chemistry in December of 2017:

“Critical analysis of reference studies on the toxicokinetics of aluminum-based adjuvants”

“We reviewed the three toxicokinetic reference studies commonly used to suggest that aluminum (Al)-based adjuvants are innocuous. A single experimental study was carried out using isotopic 26Al (Flarend et al., Vaccine, 1997). This study used aluminum salts resembling those used in vaccines but ignored adjuvant uptake by cells that was not fully documented at the time. It was conducted over a short period of time (28 days) and used only two rabbits per adjuvant. At the endpoint, Al elimination in the urine accounted for 6% for Al hydroxide and 22% for Al phosphate, both results being incompatible with rapid elimination of vaccine-derived Al in urine. Two theoretical studies have evaluated the potential risk of vaccine Al in infants, by reference to an oral “minimal risk level” (MRL) extrapolated from animal studies. Keith et al. (Vaccine, 2002) used a high MRL (2 mg/kg/d), an erroneous model of 100% immediate absorption of vaccine Al, and did not consider renal and blood-brain barrier immaturity. Mitkus et al. (Vaccine, 2011) only considered solubilized Al, with erroneous calculations of absorption duration. Systemic Al particle diffusion and neuro-inflammatory potential were omitted. The MRL they used was both inappropriate (oral Al vs. injected adjuvant) and still too high (1 mg/kg/d) regarding recent animal studies. Both paucity and serious weaknesses of reference studies strongly suggest that novel experimental studies of Al adjuvants toxicokinetics should be performed on the long-term, including both neonatal and adult exposures, to ensure their safety and restore population confidence in Al-containing vaccines.”


2018 Lecture Series

2018 Lecture Series

2018 Future of Immunity Lecture Series

The American Academy of Pediatrics acknowledges that parents who delay or refuse vaccines tend to be highly educated and knowledgeable about vaccines.

What do they know?

Part One in the Lecture Series:

Community Immunity? Does your vaccination protect anyone else?

When: Saturday, January 20, 2018 from 1:30-4:30
Where: Discovery Hall 061 at the University of Washington, Bothell campus*
Cost: Free (but if your budget allows, $10 suggested donation at the door would be much appreciated to help cover our costs.)
Parking: On campus ($4)

Kids Allowed? Yes! We understand the challenges of parenting, and trying to sneak away. Kids are welcome, but it will likely be dull for them, so please bring quiet, diverting toys.

Featured Speakers:

Tetyana Obukhanych, Ph.D. Founding Director of Physicians for Informed Consent, and Founding Member of Building Bridges in Children’s Health

Dr. Obukhanych earned a PhD in Immunology at The Rockefeller University, New York, NY and has held postdoctoral appointments in prominent immunology laboratories affiliated with Harvard Medical School and Stanford University School of Medicine. She is a Founding Director of Physicians for Informed Consent, a non-profit organization of doctors and scientists dedicated to safeguarding informed consent in vaccination. She is the author of Vaccine Illusion, and she lectures frequently at conferences and educational events throughout North America, as well as at Building Bridges in Children’s Health (BBCH), an online community that equips parents with the knowledge of up-to-date science relevant to children’s health in order to empower them in their own communications with medical doctors. 

Mary Holland, J.D. Research Scholar and Director of the Graduate Lawyering Program at NYU School of Law

Mary Holland is a legal expert on informed consent and has testified on vaccine matters at the United Nations and in New York, California, Maine, West Virginia and Vermont legislatures. She has written often-cited law review papers, articles on vaccine law and policy, and is the co-author and co-editor of the book Vaccine Epidemic and an upcoming book about HPV vaccines. She has lectured widely and has appeared in several documentaries and on various television and radio broadcasts.


*UWB is a rented venue and not affiliated with this event. This is an Informed Choice WA event.